New research in JNCCN finds that immunotherapy from immune checkpoint (PD-1) inhibitors prior to surgery was strikingly effective for patients with localized mismatch repair-deficient or microsatellite instability-high (dMMR/MSI-H) colorectal cancer (CRC).
Tag: colorectal cancer research
Rutgers Cancer Institute of New Jersey Experts Available to Discuss Colorectal Cancer Topics through March
Various specialists from Rutgers Cancer Institute of New Jersey are available for comment on colorectal cancer topics during the month of March to highlight colorectal cancer awareness month.